Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An Observational, Cohort study to evaluate the safety and efficacy of Ledipasvir/Sofosbuvir in chronic Hepatitis C GT4-infected patients with advanced liver fibrosis

Trial Profile

An Observational, Cohort study to evaluate the safety and efficacy of Ledipasvir/Sofosbuvir in chronic Hepatitis C GT4-infected patients with advanced liver fibrosis

Completed
Phase of Trial: Phase IV

Latest Information Update: 18 May 2018

At a glance

  • Drugs Ledipasvir/sofosbuvir (Primary) ; Ribavirin
  • Indications Hepatitis C
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 18 May 2018 New trial record
    • 06 May 2018 Results published in the Journal of Infection
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top